Researchers Explore Phage Therapy as a New Weapon Against UTIs

With antibiotic resistance narrowing treatment options for urinary tract infections, researchers are turning to bacteriophages — viruses that selectively kill bacteria — as a potential alternative therapy. A recent expert discussion examines how phage therapy could address recurrent and drug-resistant UTIs, a condition affecting millions worldwide. The approach draws on growing clinical interest in personalized and ready-made phage preparations, though practical questions around dosing, formulation, and large-scale manufacturing are still being worked out. No phage product for UTIs has yet reached broad approval, and current evidence comes largely from early studies and individual case experience. The event stands at an exploratory stage: the scientific rationale is established, but confirmatory trials, regulatory pathways, and standardization of phage cocktails remain open.

Written by a model from the reports · updated 3 hours ago